FDA delays decision on Moderna vaccine for adolescents

The U.S. Food and Drug Administration requires more time to decide on whether to approve use of Moderna's two-dose COVID-19 vaccine on adolescents 12 to 17 years of age, the pharmaceutical company said.

from Latest News - UPI.com https://ift.tt/3pUC8l9
via IFTTT

Comments

Popular posts from this blog

Super Eagles player Ogenyi Onazi buys multi-million naira home in Lekki (photos/video)